Early preclinical development of PQR309, a novel balanced dual PI3K/mTOR inhibitor for treatment of various cancer types.
Saved in:
| Title: | Early preclinical development of PQR309, a novel balanced dual PI3K/mTOR inhibitor for treatment of various cancer types. |
|---|---|
| Authors: | Ettlin, R.1, Dieterle, W.1, Fabbro, D.1, Hebeisen, P.1, Beaufils, F.1, Hillmann, P.1, Stumm, M.1, Dimitrijević, S.1, Wymann, M.2, Cmiljanovic, N.1, Giese, B.1, Cmiljanovic, V.1 |
| Source: | Toxicology Letters. Oct2015 Supplement, Vol. 238, pS337-S338. 1p. |
| Database: | Environment Complete |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: eih DbLabel: Environment Complete An: 110009054 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Early preclinical development of PQR309, a novel balanced dual PI3K/mTOR inhibitor for treatment of various cancer types. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ettlin%2C+R%2E%22">Ettlin, R.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Dieterle%2C+W%2E%22">Dieterle, W.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Fabbro%2C+D%2E%22">Fabbro, D.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Hebeisen%2C+P%2E%22">Hebeisen, P.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Beaufils%2C+F%2E%22">Beaufils, F.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Hillmann%2C+P%2E%22">Hillmann, P.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Stumm%2C+M%2E%22">Stumm, M.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Dimitrijević%2C+S%2E%22">Dimitrijević, S.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Wymann%2C+M%2E%22">Wymann, M.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Cmiljanovic%2C+N%2E%22">Cmiljanovic, N.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Giese%2C+B%2E%22">Giese, B.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Cmiljanovic%2C+V%2E%22">Cmiljanovic, V.</searchLink><relatesTo>1</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Toxicology+Letters%22">Toxicology Letters</searchLink>. Oct2015 Supplement, Vol. 238, pS337-S338. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=eih&AN=110009054 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.toxlet.2015.08.963 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S337 Titles: – TitleFull: Early preclinical development of PQR309, a novel balanced dual PI3K/mTOR inhibitor for treatment of various cancer types. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ettlin, R. – PersonEntity: Name: NameFull: Dieterle, W. – PersonEntity: Name: NameFull: Fabbro, D. – PersonEntity: Name: NameFull: Hebeisen, P. – PersonEntity: Name: NameFull: Beaufils, F. – PersonEntity: Name: NameFull: Hillmann, P. – PersonEntity: Name: NameFull: Stumm, M. – PersonEntity: Name: NameFull: Dimitrijević, S. – PersonEntity: Name: NameFull: Wymann, M. – PersonEntity: Name: NameFull: Cmiljanovic, N. – PersonEntity: Name: NameFull: Giese, B. – PersonEntity: Name: NameFull: Cmiljanovic, V. IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 10 Text: Oct2015 Supplement Type: published Y: 2015 Identifiers: – Type: issn-print Value: 03784274 Numbering: – Type: volume Value: 238 Titles: – TitleFull: Toxicology Letters Type: main |
| ResultId | 1 |
